Mayer Arie
SEC insider (Form 3/4/5 filer). CIK 0001796583. Director at ORAMED PHARMACEUTICALS INC. (ORMP). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 31, 2025. Located in KFAR SABA, L3.
Companies Mayer Arie has filed insider reports for
- ORAMED PHARMACEUTICALS INC. (ORMP): Director
Mayer Arie
CIK: 0001796583
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ORMP
ORAMED PHARMACEUTICALS INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 31, 2025ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect30K shares- - Dec 31, 2025ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect4.9K shares- - Jun 5, 2025ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect30K shares- - Jun 5, 2025ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect7K shares-
1-4 of 4 transactions